MARSHALL WACE, LLP - DICE THERAPEUTICS INC ownership

DICE THERAPEUTICS INC's ticker is and the CUSIP is 23345J104. A total of 70 filers reported holding DICE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of DICE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$5,365,943
+399.2%
115,496
+171.8%
0.01%
+400.0%
Q4 2021$1,075,000
-22.8%
42,5000.0%0.00%
-66.7%
Q3 2021$1,392,00042,5000.01%
Other shareholders
DICE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Northpond Ventures, LLC 3,292,871$102,737,57555.73%
Sands Capital Ventures, LLC 2,748,970$85,76823.49%
OUP Management Co., LLC 268,346$8,372,39513.67%
New Leaf Venture Partners, L.L.C. 371,693$11,596,8228.40%
RA Capital Management 6,848,911$213,686,0234.33%
VR Adviser, LLC 819,000$25,552,8004.30%
SVB FINANCIAL GROUP 42,358$1,321,5703.61%
Logos Global Management LP 660,000$20,592,0002.41%
Deep Track Capital, LP 1,734,143$54,105,2622.27%
Samsara BioCapital, LLC 202,773$6,326,5181.36%
View complete list of DICE THERAPEUTICS INC shareholders